BSEBoard Meeting6d ago · 24 Aug 2026, 06:10 pm

Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 ,inter alia, to consider and approve (i)discussion and consideration ....

Wardwizard Healthcare Ltd · 512063

✦ AI SummaryFundraise

Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 31/08/2026 to consider and approve proposal for raising further capital, increase in authorized share capital, and consequential alteration of the capital clause.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Wardwizard Healthcare Ltd - 512063 - Board Meeting Intimation for Discussion And Consideration Of Proposal For Raising Further Capital And Any Other Business As Per Details Attach Herewith

Attachments (1)

📄

ad36ffa7-a41e-4889-a602-1758e8717221.pdf

pdf

Download →
View document text
Date: 24 /08/2026 Ref: WHL/BSE/BM-INTIMATION-3 /2026-27 BSE Limited Kind Attn.: Corporate Relations Department Corporate Relations Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 Ref: - Wardwizard Healthcare Limited (BSE Script code: 512063) Subject: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended from time to time, we hereby inform you that a Meeting of the Board of Directors of the Company has been scheduled to be held on Monday, 31th Day of August, 2026 to inter-alia transact the following business: (i) To discuss and consider proposal for raising further capital and to create, offer, issue and allot such number of equity shares and equity linked instruments or securities, including convertible preference shares, non-convertible debt instruments along with warrants, fully convertible debentures, partly convertible debentures, and/or any other securities convertible into equity shares (including warrants or otherwise), Global Depository Receipts, American Depository Receipts, Foreign Currency Convertible Bonds, through public and/or private offerings and/or by way of qualified institutional placement, and / or preferential allotment and / or through any other permissible mode in accordance with the relevant provisions of applicable law or any combination thereof, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to such governmental/ statutory/regulatory and other approvals as may be required including the approval of the shareholders of the Company in the ensuing General Meeting. (ii) Increase in the Authorized Share Capital of the Company and Consequential Alteration of the Capital Clause (Clause V) of the Memorandum of Association. (iii) Any other matter with permission of the Chair We further wish to inform you that in terms of the provision of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company’s Code of Fair Disclosure and Code of Conduct for Prevention of Insider Trading, the trading window for dealing in securities of the Company, will be closed from 24th August, 2026, for all the Designated / Connected persons and their immediate relatives till 48 hours after the announcement of outcome of the Board Meeting Kindly take note of the same in your records. Thanking you, For WARDWIZARD HEALTHCARE LIMITED RAJBALA KIRORIWAL Company Secretary and Compliance Officer Membership no. A51986